Ditchcarbon
  • Customers
  1. Organizations
  2. Akorn
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Akorn

Company website

Akorn, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 1971, the company has established itself as a leader in the development, manufacturing, and marketing of specialty pharmaceuticals, particularly in the areas of ophthalmology, anaesthesia, and injectables. With a diverse portfolio of products, Akorn is recognised for its commitment to quality and innovation, offering unique formulations that cater to specific patient needs. The company has achieved significant milestones, including the expansion of its manufacturing capabilities and a robust pipeline of generic and branded medications. Akorn's strategic focus on niche markets has solidified its position as a trusted provider in the competitive pharmaceutical landscape.

DitchCarbon Score

How does Akorn's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Akorn's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Akorn's reported carbon emissions

As of the latest available data, Akorn has not reported any specific carbon emissions figures, indicating a lack of transparency in their environmental impact. There are no documented emissions in kg CO2e, nor are there any established reduction targets or climate pledges. This absence of data suggests that Akorn may not currently have a formalised strategy for addressing carbon emissions or climate commitments. In the context of the pharmaceutical industry, where sustainability is increasingly becoming a priority, Akorn's lack of emissions data and reduction initiatives may place it at a disadvantage compared to competitors who are actively engaging in climate action. Without specific targets or commitments, it remains unclear how Akorn plans to contribute to global efforts in reducing greenhouse gas emissions. Overall, Akorn's current stance on carbon emissions and climate commitments appears to be minimal, with no significant initiatives or targets reported.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Akorn's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Akorn is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Akorn is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Fagron

NL
•
Health and social work services (85)
Updated about 18 hours ago

Accord Healthcare Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Sucampo Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Ironwood Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Pacira BioSciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250804.4
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy